| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $39.6M | -71.9% |
| SG&A Expense | $47.6M | -23.6% |
| Operating Income | -$159.2M | +29.7% |
| Interest Expense | $5.2M | +176.6% |
| Pre-tax Income | -$156.1M | +30.7% |
| Income Tax | $0 | +100.0% |
| Net Income | -$156.1M | +30.1% |
| EPS (Basic) | -$24.00 | -1295.3% |
| EPS (Diluted) | -$24.00 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.2M | -79.0% |
| Short-term Investments | $141.2M | -35.0% |
| Current Assets | $160.8M | -40.3% |
| Total Assets | $325.6M | -32.5% |
| Current Liabilities | $10.6M | -67.8% |
| Total Liabilities | $99.8M | -15.8% |
| Stockholders' Equity | $225.8M | -37.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$82.0M | +54.5% |
| Capital Expenditures | $20.7M | -75.6% |
| Investing Cash Flow | $41.1M | -64.1% |
| Financing Cash Flow | $8.1M | -88.8% |
| Free Cash Flow | -$102.7M | +61.2% |
| -1295.3% |